ONCY
NASDAQ
$0.85
Oncolytics Biotech Inc (ONCY)
Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. The company is headquartered in Calgary, Canada.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $5.07 (+496.47%)
Market Cap
$105M
Free Cash Flow Yield
-19.16%
Beta (5Y)
0.88
Price Chart
Valuation
Market Cap$105M
Forward P/E45.45
P/S58.60
P/B1055.04
Profitability
EBITDA-$29M
EPS-$0.27
Financial Health
Free Cash Flow Yield-19.16%
Growth & Risk
Beta (5Y)0.88
Sharpe Ratio-0.12